QuickView for DCK;jsessionid=6EBD80B6C8AA59311B53DD1B5C8A88C0;jsessionid=6D0600F578E48C641CA4756BE79F6A18;jsessionid=699D037B1DFAF8F443EA76DCB130DA67;jsessionid=1AED1FE521A314A56D3AB342C3216688;jsessionid=0F8CA3F1EC61E2361F61793631FFFA7E;jsessionid=1735EDD2AE972ECC33BB8AFDCE54BE97 (gene)

1. Deoxycytidine kinase inactivation enhances gemcitabine resistance and sensitizes mitochondrial metab…
2. Deoxycytidine kinase (dCK) inhibition is synthetic lethal with BRCA2 deficiency.
3. MYC/Glutamine Dependency Is a Therapeutic Vulnerability in Pancreatic Cancer with Deoxycytidine Kina…
4. Deoxycytidine Kinase (DCK) Mutations in Human Acute Myeloid Leukemia Resistant to Cytarabine.
5. Effect of dexamethasone on the antileukemic effect of cytarabine: role of deoxycytidine kinase.

There were no clinical trials for DCK;jsessionid=6EBD80B6C8AA59311B53DD1B5C8A88C0;jsessionid=6D0600F578E48C641CA4756BE79F6A18;jsessionid=699D037B1DFAF8F443EA76DCB130DA67;jsessionid=1AED1FE521A314A56D3AB342C3216688;jsessionid=0F8CA3F1EC61E2361F61793631FFFA7E;jsessionid=1735EDD2AE972ECC33BB8AFDCE54BE97